Insulin resistance and atherosclerosis in branch retinal vein occlusion

Japanese Journal of Ophthalmology

Volumn 47, Issue 4, 2003, Pages 351-355

  Ogawa, Osamu ^a   Onuma, Tomio ^a   Uchino, Hiroshi ^a   Takayanagi, Yoshinori ^b   Tanaka, Yasushi ^a   Yamasaki, Yoshimitsu ^c   Atsumi, Yoshihito ^d   Matsuoka, Kenpei ^d   Kawamori, Ryuzo ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Takayanagi Eye Clinic   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SAISEIKAI CENTRAL HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Branch retinal vein occlusion; Insulin resistance

Indexed keywords

ADULT; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; IMMUNOREACTIVITY; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA VEIN OCCLUSION;

EID: 0037709013     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(03)00059-5     Document Type: Article

References (26)

1. Rath E.Z., Frank R.N., Shin D.H., Kim C. Risk factors for retinal vein occlusions. A case-control study. Ophthalmology. 99:1992;509-514.
2. The Eye Disease Case-control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol. 116:1993;286-296.
3. DeFronzo R.A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:1991;173-194.
4. Pyorala M., Miettinen H., Halonen P., Laakso M., Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol. 20:2000;538-544.
5. Shinozaki K., Naritomi H., Shimizu T., et al. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke. 27:1996;37-43.
6. Lockwood A., Clearkin L.G. Insulin resistance in retinal vein occlusion and glaucoma. Lancet. 340:1992;1100-1101.
7. Tanaka Y., Atsumi Y., Asahina T., et al. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects. Diabetes Care. 21:1998;1133-1137.
8. Yamasaki Y., Kawamori R., Matsushima H., et al. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes. 43:1994;634-639.
9. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation . Diabet Med. 15:1998;539-553.
10. Matsumoto K., Miyake S., Yano M., Ueki Y., Tominaga Y. High serum concentrations of soluble E-selectin in patients with impaired glucose tolerance with hyperinsulinemia. Atherosclerosis. 152:2000;415-420.
11. Kawamori R., Yamasaki Y., Matsushima H., et al. Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care. 15:1992;1290-1294.
12. Kawamori R. Asymptomatic hyperglycaemia and early atherosclerotic changes. Diabetes Res Clin Pract. 40:(Suppl):1998;S35-S42.
13. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
14. Frangieh G.T., Green W.R., Barraquer-Somers E., Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol. 100:1982;1132-1140.
15. Ueda Y., Kanazawa S., Ohira A., et al. Retinal vascular obstruction and asymptomatic cerebral infarction. Jpn J Ophthalmol. 46:2002;209-214.
16. Shinozaki K., Hattori Y., Suzuki M., et al. Insulin resistance as an independent risk factor for carotid artery wall intima media thickening in vasospastic angina. Arterioscler Thromb Vasc Biol. 17:1997;3302-3310.
17. Howard G., O'Leary D.H., Zaccaro D., et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation. 93:1996;1809-1817.
18. Kaplan N.M. The deadly quartet. Upper-body obesity, glucose intolererance, hypertriglyceridemia, and hypertension. Arch Intern Med. 149:1989;1514-1520.
19. Loewenstein A., Goldstein M., Winder A., Lazar M., Eldor A. Retinal vein occlusion associated with methylene-tetrahydrofolate reductase mutation. Ophthalmology. 106:1999;1817-1820.
20. Cobo-Soriano R., Sanchez-Ramon S., Aparicio M.J., et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol. 128:1999;725-732.
21. Glueck C.J., Bell H., Vadlamani L., et al. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol. 117:1999;43-49.
22. McGill J.B., Schneider D.J., Arfken C.L., Lucore C.L., Sobel B.E. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes. 43:1994;104-109.
23. Ehrmann D.A., Schneider D.J., Sobel B.E., et al. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 82:1997;2108-2116.
24. Calles-Escandon J., Mirza S.A., Sobel B.E., Schneider D.J. Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects. Diabetes. 47:1998;290-293.
25. Festa A., D'Agostino R. Jr., Mykkanen L., et al. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol. 19:1999;562-568.
26. Sobel B.E. Insulin resistance and thrombosis: a cardiologist's view. Am J Cardiol. 84:1999;37J-41J.